Last reviewed · How we verify

NCT03778476

Isometric Exercise and Endogenous Pain Inhibition

Completed NA Last updated 24 February 2021
What this trial tests

NA trial testing Isometric Exercise in Fibromyalgia in 43 participants. Completed in 29 October 2019.

Timeline
25 May 2018
Primary endpoint
29 September 2019
29 October 2019

Quick facts

Lead sponsorMarquette University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment43
Start date25 May 2018
Primary completion29 September 2019
Estimated completion29 October 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Marquette University

Who can join

Adults 18 to 75, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to identify the acute effects of isometric exercise on the inhibition of pain in individuals with fibromyalgia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impaired conditioned pain modulation was restored after a single exercise session in individuals with and without fibromyalgia.
    Alsouhibani A, Hoeger Bement M. · · 2022 · cited 11× · PMID 35399187 · DOI 10.1097/pr9.0000000000000996

Verify or expand the search:

Other trials of Isometric Exercise

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Marquette University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778476.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing